Author Question: A client is being treated with amphotericin B for a serious systemic fungal infection. The nurse ... (Read 100 times)

rmenurse

  • Hero Member
  • *****
  • Posts: 513
A client is being treated with amphotericin B for a serious systemic fungal infection. The nurse instructs the client to immediately report which adverse effects associated with this medication?
 
  Standard Text: Select all that apply.
  1. Loss of hearing
  2. Visual disturbances
  3. Dizziness
  4. Ringing in the ears
  5. Nausea and vomiting

Question 2

The nurse is providing discharge education for the patient with tinea corporis who will be taking nystatin cream. What instructions should the nurse include?
 
  1. Wash your hair at least three times a day for 2 weeks.
  2. Do not share any towels with family members.
  3. Comb the medication into your hair and cover with a towel.
  4. Avoid meat and high-protein foods while taking this medication.



nixon_s

  • Sr. Member
  • ****
  • Posts: 359
Answer to Question 1

Correct Answer: 1,3,4
Rationale 1: Amphotericin B can cause ototoxicity potentially affecting both branches, cochlear and vestibular, of cranial nerve VIII. A loss of hearing can be indicative of ototoxicity and should be reported.
Rationale 2: Visual disturbances are not caused by this medication.
Rationale 3: Amphotericin B can cause ototoxicity potentially affecting both branches, cochlear and vestibular, of cranial nerve VIII. Dizziness can be indicative of ototoxicity and should be reported.
Rationale 4: Amphotericin B can cause ototoxicity potentially affecting both branches, cochlear and vestibular, of cranial nerve VIII. A ringing in the ears can be indicative of ototoxicity and should be reported.
Rationale 5: At the onset of therapy, as many as 50 of patients experience acute, infusion-related fever and chills, vomiting, anorexia, and headache. These symptoms usually subside as treatment continues and would not need to be reported.
Global Rationale: Amphotericin B can cause ototoxicity potentially affecting both branches, cochlear and vestibular, of cranial nerve VIII. A loss of hearing and ringing in the ears can be indicative of ototoxicity and should be reported. At the onset of therapy, as many as 50 of patients experience acute, infusion-related fever and chills, vomiting, anorexia, and headache. These symptoms usually subside as treatment continues and would not need to be reported. Visual disturbances are not caused by this medication.

Answer to Question 2

Correct Answer: 2
Rationale 1: The client should wash the hair at the usual frequency.
Rationale 2: Not sharing towels helps prevent the spread of the disease.
Rationale 3: Combing the medication into the hair is not necessary.
Rationale 4: There are no dietary restrictions with this medication, which is administered externally.
Global Rationale: Tinea corporis is a fungal infection of the skin. Not sharing towels helps to prevent spread of the disease. Hair should be washed at normal intervals and combing the medication into the hair is not indicated for this condition. There are no dietary restrictions.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question


 

Did you know?

In the United States, there is a birth every 8 seconds, according to the U.S. Census Bureau's Population Clock.

Did you know?

Essential fatty acids have been shown to be effective against ulcers, asthma, dental cavities, and skin disorders such as acne.

Did you know?

Automated pill dispensing systems have alarms to alert patients when the correct dosing time has arrived. Most systems work with many varieties of medications, so patients who are taking a variety of drugs can still be in control of their dose regimen.

Did you know?

Adults are resistant to the bacterium that causes Botulism. These bacteria thrive in honey – therefore, honey should never be given to infants since their immune systems are not yet resistant.

Did you know?

Despite claims by manufacturers, the supplement known as Ginkgo biloba was shown in a study of more than 3,000 participants to be ineffective in reducing development of dementia and Alzheimer’s disease in older people.

For a complete list of videos, visit our video library